JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BRSP
2026
BrightSpire Capital
BRSP
$485M
| $15.1M | ﹤0.01% |
2,030,257
+1,400,717
| +222% | +$9.14M |
2018 Q2
22 quarters
|
|
2027
Haemonetics
HAE
$4.75B
| $15.1M | ﹤0.01% |
176,339
+4,962
| +3% | +$429K |
2015 Q4
32 quarters
|
|
2028
IPG Photonics
IPGP
$3.56B
| $15.1M | ﹤0.01% |
138,907
+49,522
| +55% | +$4.8M |
2015 Q4
32 quarters
|
|
2029
GATX Corp
GATX
$5.96B
| $15.1M | ﹤0.01% |
125,326
-13,335
| -10% | -$1.47M |
2013 Q2
42 quarters
|
|
2030
InvenTrust Properties
IVT
$2.37B
| $15.1M | ﹤0.01% |
594,321
+369,043
| +164% | +$9.2M |
2021 Q4
8 quarters
|
|
2031
Malibu Boats
MBUU
$449M
| $15M | ﹤0.01% |
274,496
+15,168
| +6% | +$727K |
2014 Q1
39 quarters
|
|
2032
CNO Financial Group
CNO
$4.91B
| $15M | ﹤0.01% |
538,790
+3,508
| +0.7% | +$88.4K |
2013 Q2
42 quarters
|
|
2033
Madison Square Garden
MSGS
$9.61B
| $15M | ﹤0.01% |
82,630
+2,333
| +3% | +$404K |
2013 Q2
42 quarters
|
|
2034
PUT
Nike
NKE
$52.1B
| $15M | ﹤0.01% |
138,100
-12,700
| -8% | -$1.36M |
2016 Q1
31 quarters
|
|
2035
Old Second Bancorp
OSBC
$1.25B
| $15M | ﹤0.01% |
969,762
+54,014
| +6% | +$781K |
2016 Q4
28 quarters
|
|
2036
Bio-Rad Laboratories Class A
BIO
$9.51B
| $15M | ﹤0.01% |
46,364
+8,469
| +22% | +$2.65M |
2013 Q2
42 quarters
|
|
2037
Adeia
ADEA
$2.79B
| $15M | ﹤0.01% |
1,208,035
+28,889
| +2% | +$279K |
2015 Q4
32 quarters
|
|
|
PARA
2038
CALL
DELISTED
Paramount Global Class B
PARA
| $14.9M | ﹤0.01% |
1,010,100
-400,000
| -28% | -$5.35M |
2022 Q1
7 quarters
|
|
2039
International Seaways
INSW
$5.68B
| $14.9M | ﹤0.01% |
328,355
+19,411
| +6% | +$893K |
2016 Q4
28 quarters
|
|
2040
Zions Bancorporation
ZION
$9.14B
| $14.9M | ﹤0.01% |
340,402
-42,812
| -11% | -$1.55M |
2013 Q2
42 quarters
|
|
2041
STMicroelectronics
STM
$47.7B
| $14.9M | ﹤0.01% |
296,831
-329,688
| -53% | -$14.8M |
2015 Q1
35 quarters
|
|
2042
Alector
ALEC
$208M
| $14.9M | ﹤0.01% |
1,863,998
-424,371
| -19% | -$2.51M |
2019 Q1
19 quarters
|
|
2043
Schwab US Mid-Cap ETF
SCHM
$14.4B
| $14.9M | ﹤0.01% |
592,404
+523,119
| +755% | +$12M |
2022 Q3
5 quarters
|
|
2044
RingCentral
RNG
$6.54B
| $14.9M | ﹤0.01% |
437,720
+275,373
| +170% | +$8.23M |
2013 Q4
40 quarters
|
|
2045
Ryder
R
$8.86B
| $14.8M | ﹤0.01% |
128,542
-13,646
| -10% | -$1.44M |
2013 Q2
42 quarters
|
|
2046
StoneX
SNEX
$7.89B
| $14.8M | ﹤0.01% |
676,043
-165,122
| -20% | -$3.14M |
2015 Q2
34 quarters
|
|
|
MPT
2047
Medical Properties Trust
MPT
$2.01B
| $14.8M | ﹤0.01% |
3,010,576
+897,743
| +42% | +$4.4M |
2013 Q2
42 quarters
|
|
2048
Carvana
CVNA
$45.4B
| $14.8M | ﹤0.01% |
1,395,725
+678,040
| +94% | +$5.08M |
2017 Q2
26 quarters
|
|
2049
Scansource
SCSC
$1.25B
| $14.8M | ﹤0.01% |
373,019
+4,118
| +1% | +$139K |
2015 Q4
32 quarters
|
|
|
JHG
2050
DELISTED
Janus Henderson
JHG
| $14.8M | ﹤0.01% |
489,650
+19,545
| +4% | +$505K |
2017 Q2
26 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.